Luke A McGuinness
Overview
Explore the profile of Luke A McGuinness including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
33955
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lee M, Hatcher C, McGuinness L, McBride N, Battram T, Wan W, et al.
Wellcome Open Res
. 2024 Jul;
7:308.
PMID: 38974363
Mendelian randomization (MR) is increasingly used for generating estimates of the causal impact of exposures on outcomes. Evidence suggests a causal role of excess adipose tissue (adiposity) on many health...
2.
Data extraction methods for systematic review (semi)automation: Update of a living systematic review
Schmidt L, Finnerty Mutlu A, Elmore R, McGuinness L, Olorisade B, Thomas J, et al.
F1000Res
. 2023 Oct;
10:401.
PMID: 34408850
The reliable and usable (semi)automation of data extraction can support the field of systematic review by reducing the workload required to gather information about the conduct and results of the...
3.
Knipe D, John A, Padmanathan P, Eyles E, Dekel D, Higgins J, et al.
PLOS Glob Public Health
. 2023 Mar;
2(6):e0000282.
PMID: 36962383
There is widespread concern over the potential impact of the COVID-19 pandemic on suicide and self-harm globally, particularly in low- and middle-income countries (LMIC) where the burden of these behaviours...
4.
Haddaway N, Page M, Pritchard C, McGuinness L
Campbell Syst Rev
. 2023 Mar;
18(2):e1230.
PMID: 36911350
Background: Reporting standards, such as PRISMA aim to ensure that the methods and results of systematic reviews are described in sufficient detail to allow full transparency. Flow diagrams in evidence...
5.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C, et al.
Rev Panam Salud Publica
. 2023 Jan;
46:e112.
PMID: 36601438
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors...
6.
Cheng H, French C, Salam A, Dawson S, McAleenan A, McGuinness L, et al.
Emerg Infect Dis
. 2022 Jul;
28(8):1559-1568.
PMID: 35876478
Ribavirin has been used widely to treat Lassa fever in West Africa since the 1980s. However, few studies have systematically appraised the evidence for its use. We conducted a systematic...
7.
Eyles E, Moran P, Okolie C, Dekel D, Macleod-Hall C, Webb R, et al.
J Affect Disord Rep
. 2021 Nov;
6:100271.
PMID: 34841385
Background: The COVID-19 pandemic has had an impact on the mental health of healthcare and social care workers, and its potential effect on suicidal thoughts and behaviour is of particular...
8.
Andrews L, Thornton Z, Saincher S, Yao I, Dawson S, McGuinness L, et al.
Neuro Oncol
. 2021 Oct;
24(4):528-540.
PMID: 34718782
Background: Detailed prevalence estimates of BRAFV600 mutations and BRAF inhibitor (BRAFi) treatment responses in V600-mutant glioma will inform trial development. Methods: Our systematic review analyzed overall prevalence of BRAFV600 mutations...
9.
Page M, McKenzie J, Bossuyt P, Boutron I, Hoffmann T, Mulrow C, et al.
Rev Esp Cardiol (Engl Ed)
. 2021 Aug;
74(9):790-799.
PMID: 34446261
The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors...
10.
Hennessy E, Acabchuk R, Arnold P, Dunn A, Foo Y, Johnson B, et al.
Prev Sci
. 2021 Jul;
23(5):809-820.
PMID: 34291384
When seeking to inform and improve prevention efforts and policy, it is important to be able to robustly synthesize all available evidence. But evidence sources are often large and heterogeneous,...